Dynavax Technologies (DVAX)
(Real Time Quote from BATS)
$10.96 USD
-0.23 (-2.06%)
Updated Sep 11, 2024 01:44 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Dynavax Technologies (DVAX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$24.00 | $29.00 | $15.00 | 114.48% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Dynavax Technologies comes to $24.00. The forecasts range from a low of $15.00 to a high of $29.00. The average price target represents an increase of 114.48% from the last closing price of $11.19.
Analyst Price Targets (4 )
Broker Rating
Dynavax Technologies currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.40 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy, representing 80% of all recommendations. A month ago, Strong Buy represented 80%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.40 | 1.40 | 1.40 | 1.40 | 1.40 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/9/2024 | JMP Securities | Roy Buchanan | Strong Buy | Strong Buy |
8/8/2024 | Goldman Sachs | Paul K Choi | Hold | Hold |
5/9/2024 | H.C. Wainwright & Co. | Edward White | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Philip M Nadeau | Strong Buy | Strong Buy |
2/23/2024 | William Blair | Matt Phipps | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.40 |
ABR (Last week) | 1.40 |
# of Recs in ABR | 5 |
Average Target Price | $24.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | 0.10 |
DVAX FAQs
Dynavax Technologies Corporation (DVAX) currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Dynavax Technologies Corporation (DVAX) is $24.00. The current on short-term price targets is based on 3 reports.
The forecasts for Dynavax Technologies Corporation (DVAX) range from a low of $15 to a high of $29. The average price target represents a increase of $114.48 from the last closing price of $11.19.
The current UPSIDE for Dynavax Technologies Corporation (DVAX) is 114.48%
Based on short-term price targets offered by four analysts, the average price target for Dynavax Technologies comes to $24.00. The forecasts range from a low of $15.00 to a high of $29.00. The average price target represents an increase of 114.48% from the last closing price of $11.19.